GRAY News and Press, Graybug Vision Inc. From 05/12/21

REDWOOD CITY, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today provided an update on recent corporate dev...

GB-102 1mg has shown competitive durability and anatomical control versus aflibercept Trend in mean BCVA of GB-102 1mg compared to aflibercept driven primarily by a subgroup of patients Developing enhanced formulations and seeking partner funding for additional clinical ...

REDWOOD CITY, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today announced it will host a conference call a...

Shares of Graybug Vision Inc. (NASDAQ:GRAY) traded at a new 52-week low today of $4.46. So far today approximately 488,000 shares have been exchanged, as compared to an average 30-day volume of 986,000 shares. Graybug Vision Inc. (NASDAQ:GRAY) has potential upside of 0.3% based on a curr...

Shares of Graybug Vision Inc. (NASDAQ:GRAY) traded at a new 52-week low today of $4.66. So far today approximately 488,000 shares have been exchanged, as compared to an average 30-day volume of 986,000 shares. Over the past year, Graybug Vision Inc. has traded in a range of $4.66 to $37....

Shares of Graybug Vision Inc. (NASDAQ:GRAY) traded at a new 52-week low today of $4.69. This new low was reached on below average trading volume as 488,000 shares traded hands, while the average 30-day volume is approximately 986,000 shares. In the past 52 weeks, shares of Graybug Vision...

Shares of Graybug Vision Inc. (NASDAQ:GRAY) traded today at $4.71, breaking its 52-week low. Approximately 488,000 shares have changed hands today, as compared to an average 30-day volume of 986,000 shares. In the past 52 weeks, Graybug Vision Inc. share prices are bracketed by a current...

Graybug Vision Inc. (NASDAQ:GRAY) traded at a new 52-week low today of $4.47. This new low was reached on below average trading volume as 488,000 shares traded hands, while the average 30-day volume is approximately 986,000 shares. Graybug Vision Inc is a clinical-stage biopharmaceutical...

The clinical-stage clinical-stage biopharma Graybug Vision ([[GRAY]] -14.3%) and precision oncology company PMV Pharmaceuticals ([[PMVP]] -14.2%) have lost double-digit percentage points so far as their lock-up agreements expire.Both companies went public in September 2020. Since then PMV Pha...

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. A round of late-afternoon buying boosted the Dow Jones average to another record high on Friday as rising optimism around the global economic...